A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2629-2633

  Lety, M A ^a   Nair, S ^a   Berche, P ^a   Escuyer, V ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOGALACTAN; ARABINOMANNAN; ETHAMBUTOL; ISONIAZID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; CONTROLLED STUDY; DRUG TARGETING; GENE LOCUS; MISSENSE MUTATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0030734124     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2629     Document Type: Article

References (36)

1. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. Sun Um, T. M. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
2. Belanger, A. E., G. S. Besra, M. E. Ford, K. Mikusovà, J. T. Belisle, P. J. Brennan, and J. M. Inamine. 1996. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimyeobacterial drug ethambutol. Proc. Natl. Acad. Sci. USA 93:11919-11924.
3. Bloom, B. R., and C. J. L. Murray. 1992. Tuberculosis: commentary on a resurgent killer. Science 257:1055-1064.
4. Centers for Disease Control. 1991. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infectcd persons - Florida and New York, 1988-1991. Morbid. Mortal. Weekly Rep. 40:585-591.
5. Cheema, S., S. Astora, and G. K. Khuller. 1985. Ethambutol induced leakage of phospholipids in Mycobacterium smegmatis. IRCS (Int. Res. Commun. Syst.) Med. Sci. 13:843-844.
6. Clark-Curtis, J. E. 1990. Genome structure of mycobacteria, p. 77-96. In J. McFaden (ed.), Molecular biology of the mycobacteria. Surrey University Press, Academic Press, London, United Kingdom.
7. Deng, L., K. Mikusovà, K. G. Robuck, M. Scherman, P. J. Brennan, and M. R. McNeil. 1995. Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicrob. Agents Chemother. 39:694-701.
8. Finken, M., P. Kirschner, A. Meier, A. Wrede, and E. C. Böttger. 1993. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol. Microbiol. 9:1239-1246.
9. Forbes, M., N. A. Kuck, and E. A. Peets. 1965. Effect of ethambutol on nucleic acid metabolism in Mycobacterium smegmatis and its reversal by polyamines and divalent cations. J. Bacteriol. 89:1299-1305.
10. Frieden, T. R., T. Sterling, A. Pablos-Mendez, J. O. Kilburn, J. O. Cauthen, and S. W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328:521-526.
11. Garbe, T. R., J. Barathi, S. Barnini, Y. Zhang, C. Abou-Zeid, D. Tang, R. Mukherjee, and D. B. Young. 1994. Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 140:133-138.
12. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
13. Hinshelwood, S., and N. G. Stoker. 1992. An Escherichia coli-Mycobacterium shuttle cosmid vector pMSC1. Gene 110:115-118.
14. Jacobs, W. R., Jr., G. V. Kalpana, J. D. Cirillo, L. Pascopella, S. B. Snapper, R. A. Udani, W. Jones, R. G. Barletta, and B. Bloom. 1991. Genetic systems for mycobacteria. Methods Enzymol. 204:537-555.
15. Kallenius, G. S., S. B. Svenson, and S. E. Hoffner. 1989. Ethambutol: a key for Mycobacterium avium complex chemotherapy? Am. Rev. Respir. Dis. 140:264.
16. Kilburn, J. O., K. Takayama, E. L. Armstrong, and J. Greenberg. 1981. Effects of ethambutol on phospholipid metabolism in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 19:346-348.
17. Lee, M. H., L. Pascopella, W. R. Jacobs, Jr., and G. F. Hatfull. 1991. Site-specific integration of mycobacteriophage L5: integration proficient vectors for Mycobacterium smegmatis, BCG, and M. tuberculosis. Proc. Natl. Acad. Sci. USA 88:3111-3115.
18. Masur, H. 1993. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 329:898-904.
19. Mikusovà, K., R. A. Slayden, G. S. Besra, and P. J. Brennan. 1995. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob. Agents Chemother. 39:2484-2489.
20. Pascopella, L., F. M. Collins, J. M. Martin, M. H. Lee, G. F. Hatfull. C. K. Stover, B. R. Bloom, and W. R. Jacobs, Jr. 1994. Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment assocated with virulence. Infect. Immun. 62:1313-1319.
21. Poso, H., L. Paulin, and E. Brander. 1983. Specific inhibition of spermidine synthase from mycobacteria by ethambutol. Lancet ii:1418.
22. Raleigh, E. A., N. E. Murray, H. Revel, R. M. Blumenthal, D. Westaway, A. D. Reith, P. W. J. Rigby, J. Elhai, and D. Hanahan. 1988. McrA and McrB restriction phenotypes of some Escherichia coli strains and implications for gene cloning. Nucleic Acids Res. 16:1563-1575.
23. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
24. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nature Med. 2:662-667.
25. Silve, G., P. Valero-Guillen, A. Quemard, M.-A. Dupont, M. Daffe, and G. Lanelle. 1993. Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug. Antimicrob. Agents Chemother. 37:1536-1538.
26. Snapper, S. B., R. E. Melton, S. Mustafa, T. Kieser, and W. R. Jacobs, Jr. 1990. Isolation and characterization of efficient transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1911-1919.
27. Snider, D. E., Jr., and W. L. Roper. 1992. The new tuberculosis. N. Engl. J. Med. 326:703-705.
28. Takayama, K., and J. O. Kilburn. 1989. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 33:1493-1499.
29. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodner. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
30. Telenti, A., W. J. Philip, S. Sreevatsan, C. Bernasconi, K. E. Stockbauer, B. Wieles, J. M. Musser, and W. R. Jacobs. 1997. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nature Med. 3:567-570.
31. Wilson, T. M. 1970. Clinical experience with ethambutol. Antibiot. Chemother. 16:222-229.
32. Wilson, T. M., and D. M. Collins. 1996. ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol. Microbiol. 19:1025-1034.
33. Winder, F. G. 1982. Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria, p. 354-442. In C. Ratledge and J. Standford (ed.), The biology of the mycobacteria, vol. 1. Academic Press, London, United Kingdom.
34. Wolucka B. A., M. R. McNeil, E. de Hoffmann, T. Chojnacki, and P. J. Brennan. 1994. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J. Biol. Chem. 269:23328-23335.
35. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance in Mycobacterium tuberculosis. Nature 358:591-593.
36. Zhang, Y., T. Garbe, and D. Young. 1993. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol. Microbiol. 8:521-524.